Arteris, Inc. heads into the final weeks before its July earnings with a striking divergence: short sellers are rebuilding positions at pace just as company insiders are taking money off the table — and both groups are doing so after a stock that has more than doubled this year.
The insider activity is the most concrete signal this week. Multiple directors and the General Counsel sold shares between June 1 and June 4, with director Saiyed Atiq Raza alone offloading over $2.8 million across several transactions near the $36–$38 level. An independent director added a further ~$760,000 in sales over the same window. The 90-day net picture is complicated — net shares are technically positive at 766,000 — but the recent cluster of outright open-market sales by named directors, executed at multi-year highs, is a different signal from routine plan activity. It is worth noting that the 90-day net value figure of ~$23.9 million likely reflects earlier option-related activity, so the directional read from the past two weeks is unambiguously sell-side.
Short interest corroborates that caution. Bears have added aggressively — short interest climbed 13% over the week to roughly 3.9% of the free float, and is up 69% from a month ago when positions were closer to 2.3%. The absolute level remains moderate rather than extreme, and the lending market is nowhere near tight: availability is exceptionally loose at over 5,500% of short interest, meaning shares to borrow vastly outnumber what is already borrowed, and cost to borrow is a negligible 0.51%. That combination — rising short positions but ample borrow supply — suggests new shorts are entering at will, not fighting a crowded or constrained market. The ORTEX short score has ticked up to 36 from a recent low of 34.5, confirming the gradual directional shift but not yet reaching levels that signal serious squeeze risk.
Options positioning adds a mild layer of defensiveness without screaming alarm. The put/call ratio has edged up to 0.26, above its 20-day average of 0.23, placing it less than one standard deviation above the mean. Relative to the 52-week range of 0.02 to 0.29, the reading is close to the top of the range, but the absolute level is still low — calls dominate the open interest picture by a wide margin. Options traders are nudging toward more protection, not abandoning the bull thesis.
The Street view remains constructive but was last updated in mid-May. Jefferies raised its target to $35 (Hold) from $16 after the Q1 print, while TD Cowen lifted to $40 (Buy) and Rosenblatt moved to $38 (Buy) — all three actions from May 13, representing a meaningful reset higher after the earnings beat. At the current price of $33.76, AIP trades modestly below the mean target of $37.75, implying modest upside relative to the rally already banked. The bull case centres on licensing revenue growth, the Cycuity acquisition driving cross-sell in data centre and automotive chips, and a path toward operating profitability by year-end. Bears point to continued losses, heavy reliance on a few verticals — automotive, AI/ML, 5G — and the threat of larger players investing in in-house interconnect IP. EPS surprise ranks in the 91st percentile and the 12-month forward EPS growth estimate sits in the 96th percentile, so the fundamental momentum is real; the debate is about valuation after a 117% year-to-date run. Valuation multiples are difficult to anchor given the pre-profitability profile — PE and EV/EBITDA are distorted — making the licensing revenue trajectory the key swing variable.
The most recent earnings print (Q1, May 12) produced a 7.3% single-day gain and held a 3.8% five-day gain, confirming the market rewards beats. The next event is July 31. Between now and then, the variable to watch is whether the insider selling cluster continues to expand — additional open-market disposals from C-suite or board members near current levels would reinforce the message that those with the best information view the recent price as full.
See the live data behind this article on ORTEX.
Open AIP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
